But for others who've struggled despite "doing everything right," a single pathway isn't enough
Never adjust semaglutide dosing without guidance
"The companies and the FDA, no one's identified an endgame with these drugs," Kessler says
But with some strategies, you can dine out successfully on tirzepatide
Exclusion criteria included diagnosis of type 1 diabetes, pregnancy, use of any GLP-1 RA or DPP4i during the baseline period, use of 2 types of products in the index drug class on the index date, initiation of another new glucose-lowering drug class on the index date, bariatric surgery, or use of antiobesity medications during the study period
A few things set it apart: Transparent pricing